Although BLI is most of the time used to follow tumor and stem cells, T cells could also be monitored thanks to the luciferase gene; for instance, the migration of CD8 T cells toward tumor site was evaluated in a xenograft mouse model (83), and the migration of tumor associated macrophages has been visualized in a transgenic mouse model of ovarian cancer (84). Here, CD8A is linked to neoplasm.